La información financiera y operativa incluida en este comunicado de prensa está basada en estados contables intermedios consolidados condensados no […]
The financial and operational information contained in this press release is based on unaudited consolidated condensed interim financial statements presented […]
NOVATO, Calif., April 25, 2024 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development […]